GSK: FIRST SINGLE-DOSE MEDICINE TO PREVENT RELAPSE OF P. VIVAX MALARIA LAUNCHED IN THAILAND AND BRAZIL
Gsk: First Single-Dose Medicine To Prevent Relapse Of P. Vivax M…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,510 GBX | -0.10% |
|
-1.08% | +4.09% |
05:00pm | Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births | RE |
03:45pm | UBS Downgrades GSK to Neutral From Buy | MT |
GSK: FIRST SINGLE-DOSE MEDICINE TO PREVENT RELAPSE OF P. VIVAX MALARIA LAUNCHED IN THAILAND AND BRAZIL
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,510 GBX | -0.10% | -1.08% | 78.92B | ||
5.918 BRL | +0.19% | -2.56% | - | ||
1st Jan change | Capi. | |
---|---|---|
+4.09% | 78.92B | |
+57.50% | 823B | |
-6.92% | 353B | |
+15.52% | 320B | |
+7.34% | 295B | |
+13.62% | 239B | |
+14.55% | 220B | |
-0.33% | 219B | |
+8.23% | 167B | |
-3.04% | 159B |